These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 20173673

  • 1. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
    Mizuno O, Kawamoto H, Yamamoto N, Horiguchi S, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ishida E, Ogawa T, Okada H, Yamamoto K.
    Pancreas; 2010 Jul; 39(5):617-21. PubMed ID: 20173673
    [Abstract] [Full Text] [Related]

  • 2. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY, Park YC, Song YS, Lee SE, Hwang DW, Lim CS, Lee HE, Kim WH, Kim SW.
    J Hepatobiliary Pancreat Surg; 2009 Jul; 16(5):668-74. PubMed ID: 19412570
    [Abstract] [Full Text] [Related]

  • 3. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms.
    Kobayashi N, Inamori M, Fujita K, Fujisawa T, Fujisawa N, Takahashi H, Yoneda M, Abe Y, Kawamura H, Shimamura T, Kirikoshi H, Kubota K, Sakaguchi T, Saito S, Saubermann LJ, Nakajima A.
    J Hepatobiliary Pancreat Surg; 2008 Jul; 15(2):169-77. PubMed ID: 18392710
    [Abstract] [Full Text] [Related]

  • 4. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE, Finkelstein SD, Ohori NP.
    Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
    [Abstract] [Full Text] [Related]

  • 5. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K, Nagai H, Sakurai S, Hironaka M, Morinaga S, Saitoh K, Fukayama M.
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [Abstract] [Full Text] [Related]

  • 6. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K.
    J Hepatobiliary Pancreat Surg; 2002 Nov; 9(1):76-85. PubMed ID: 12021900
    [Abstract] [Full Text] [Related]

  • 7. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B, Yashiro M, Nishioka N, Aya M, Yamada S, Takenaka C, Ohira M, Ishikawa T, Nishino H, Wakasa K, Hirakawa K.
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas.
    Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, Mukai K, Aoki T.
    Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458
    [Abstract] [Full Text] [Related]

  • 9. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N, Ohtsuka T, Kono H, Fujiwara K, Oda Y, Aishima S, Ito T, Ishigami K, Tokunaga S, Ohuchida K, Takahata S, Nakamura M, Mizumoto K, Tanaka M.
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T, Shirai Y, Ishihara T, Sudo K, Nakagawa A, Ito H, Miyazaki M, Nomura F, Saisho H.
    Cancer; 2005 Dec 15; 104(12):2830-6. PubMed ID: 16287152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M.
    Ann Surg Oncol; 2006 Jul 15; 13(7):955-60. PubMed ID: 16788757
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas.
    Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A.
    Surgery; 2010 Aug 15; 148(2):285-90. PubMed ID: 20434746
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K, Hiyama E, Murakami Y, Kanehiro T, Ohge H, Sueda T, Yokoyama T.
    Oncol Rep; 2003 Aug 15; 10(2):277-83. PubMed ID: 12579258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs).
    Yokoyama Y, Nagino M, Oda K, Nishio H, Ebata T, Abe T, Igami T, Nimura Y.
    Surgery; 2007 Aug 15; 142(2):136-42. PubMed ID: 17689677
    [Abstract] [Full Text] [Related]

  • 19. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
    Takasu N, Kimura W, Moriya T, Hirai I, Takeshita A, Kamio Y, Nomura T.
    Pancreas; 2010 Jul 15; 39(5):604-10. PubMed ID: 20124938
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.